Protagonist Therapeutics, Inc.
USD122.70
+1.07 (+0.88%)
CEO
Dinesh V. Patel
IPO Date
2016-08-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$122.31
Prev. Close
$121.63
Day Low
$119.57
Day High
$123.53
52W Low
$49.38
52W High
$126.59
Market Cap
$7.89B
Volume
0.07M
| 8.6 |
| 31 Dec 2023 | FY | 100.0% | -131.6% | -23.5% | -22.1% | 0.00 | 16.71 | -16.5 |
| 31 Dec 2022 | FY | 100.0% | -479.3% | -59.1% | -51.4% | 0.02 | 7.80 | -4.2 |
| 31 Dec 2021 | FY | 100.0% | -458.9% | -41.8% | -36.1% | 0.02 | 7.74 | -12.6 |
| 31 Dec 2020 | FY | 100.0% | -231.1% | -23.7% | -20.4% | 0.02 | 7.84 | -10.5 |
| 31 Dec 2019 | FY | 100.0% | -33414.3% | -96.5% | -49.8% | 0.21 | 4.10 | -2.4 |
| 31 Dec 2018 | FY | 100.0% | -125.9% | 27.7% | -27.9% | 0.00 | 5.26 | -3.9 |
| 31 Dec 2017 | FY | 100.0% | -184.2% | 36.4% | -22.6% | 0.00 | 3.55 | -10.0 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 57.6% | -39.6% | 0.00 | 12.94 | -3.8 |
| -31.3 |
| 30 Sept 2025 | Q3 | 100.0% | -834.9% | -6.1% | -5.6% | 0.02 | 13.05 | -26.9 |
| 30 Jun 2025 | Q2 | 100.0% | -627.0% | -5.2% | -4.8% | 0.02 | 16.97 | -25.2 |
| 31 Mar 2025 | Q1 | 100.0% | -41.2% | -1.7% | -1.6% | 0.02 | 17.26 | -65.3 |
| 31 Dec 2024 | Q4 | 100.0% | 77.2% | 19.5% | 17.7% | 0.02 | 12.48 | 4.6 |
| 30 Sept 2024 | Q3 | 100.0% | -710.4% | -6.2% | -5.5% | 0.02 | 10.70 | -20.9 |
| 30 Jun 2024 | Q2 | 100.0% | -734.7% | -5.7% | -5.0% | 0.02 | 13.73 | -17.6 |
| 31 Mar 2024 | Q1 | 100.0% | 81.3% | 37.0% | 32.9% | 0.00 | 15.72 | 2.1 |
| 31 Dec 2023 | Q4 | 100.0% | 45.6% | 8.1% | 7.6% | 0.00 | 16.71 | 12.7 |